# Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris

> **NCT02160678** · PHASE3 · COMPLETED · sponsor: **G & W Laboratories Inc.** · enrollment: 1741 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Vehicle
- **DRUG:** Tazarotene Cream, 0.1 %
- **DRUG:** Tazorac Cream, 0.1%

## Key facts

- **NCT ID:** NCT02160678
- **Lead sponsor:** G & W Laboratories Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 1741 (ACTUAL)
- **Last updated:** 2016-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02160678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02160678, "Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02160678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*